Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Jesse McCool, PhD, brings more than two decades of leadership to the position.
January 6, 2026
By: Patrick Lavery
Florida-based contract development and manufacturing organization (CDMO) GBI Biomanufacturing has named Jesse McCool, PhD, as its new President.
McCool boasts more than two decades of experience in leadership posts in process development and clinical & commercial good manufacturing practice (GMP) manufacturing. His areas of expertise include biologics, plasmids, and advanced therapies, specifically in microbial and mammalian production platforms.
“I’m passionate about transforming scientific innovation into real-world impact,” McCool said. “To advance that mission, I have spent my career innovating and operating in the biologics CDMO industry.”
“Jesse is a highly respected executive within the biologics CDMO industry, and he brings with him a wealth of experience across numerous organizations including Lonza Group, Wheeler Bio, Cytovance Biologics, among others,” said Karl Pinto, Chairman of the Board of Directors, GBI Biomanufacturing. “His passion for biologics and commitment to customer experience and delight will ensure that GBI continues its new momentum.”
The momentum Pinto spoke of, he added, follows “significant investment and expansion” in the last several years to bring cutting-edge drugs to market.
GBI Biomanufacturing, formerly Goodwin Biotechnology, provides integrated development and current GMP (cGMP) manufacturing services for complex biologics. With McCool as its new President, GBI Biomanufacturing plans to strengthen its integrated CDMO offering. Namely, this will include helping biopharma partners reduce development and manufacturing risk.
Ways in which GBI accomplishes this include coordinated process development, analytical support, cGMP drug substance manufacturing, and aseptic fill-finish.
In February 2025, McCool, then Chief Scientific Officer of Bionova Scientific, participated in a Contract Pharma Pharma Matters Q&A. With Bionova’s Michelle Chen, Senior Vice President of Process Development and Manufacturing, and Minni Aswath, Senior Director of Process Development, McCool addressed the topics of derisking scale-up and tox supply in biologics R&D.
Read the full Q&A here.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
